Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Tickers ABBV BMY NEWS
Tags Trading Ideas News Large Cap
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Tickers BMY EVO NEWS NVO
Tags Media Benzinga General
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags BMY Briefs Market News
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Tickers AFRM BMY BTBT BTDR
Tags Benzinga Mid/Day Movers HIMS
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags Health Care LLY GILD
From Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags Benzinga Top Stories General
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags Benzinga why it's moving General
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags Market News BZI/SHORTHIST Trading Ideas
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags BMY Briefs Market News
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags Econ #s XLK $BTC
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags BMY Recent Press Releases Market News
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags Briefs BMY Guidance
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Health Care CATX Analyst Color
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags Expert Ideas Stories That Matter Biotech
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags BZI/UOA Benzinga Markets
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags Market News Movers Briefs
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags why it's moving General Benzinga
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags Analyst Color Health Care Trading Ideas
From Benzinga
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
Tickers BMY JNJ
Tags Market News BMY Recent Press Releases
From Motley Fool
Cancer-Focused Perspective Therapeutics Stock Trades Lower After Drug Study Report
Tickers BMY CATX NEWS
Tags Movers Market News BMY
From Benzinga
Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst
Tickers BMY NEWS RVPH
Tags Health Care Analyst Color News
From Benzinga
Unveiling 11 Analyst Insights On Bristol-Myers Squibb
Tickers BMY
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags HIMS MRK ZTS
From Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Tickers AAPL AI BMY GILD
Tags Benzinga Top Stories Tech
From Benzinga
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
Tickers BMY CRM PFE
Tags Market News BMY Ian Read
From Benzinga
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Tickers BMY NEWS
Tags Top Stories Benzinga General
From Benzinga
2 Passive-Income Stocks to Load Up On in October
Tickers BMY LMT
Tags Market News LMT Recent Press Releases
From Motley Fool
This Is What Whales Are Betting On Bristol-Myers Squibb
Tickers BMY
Tags BMY Market News Markets
From Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
Tickers BMY IGMS NEWS
Tags News Trading Ideas Management
From Benzinga
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Tickers BMY PRME
Tags Market News PRME Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.